Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
3,141,198
-
Share change
-
+1,298,400
-
Total reported value
-
$37,256,175
-
Price per share
-
$11.86
-
Number of holders
-
34
-
Value change
-
+$15,364,524
-
Number of buys
-
27
-
Number of sells
-
5
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2018
As of 30 Jun 2018,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,141,198 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Nantahala Capital Management, LLC, STATE STREET CORP, First Eagle Investment Management, LLC, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, MORGAN STANLEY, and TIAA CREF INVESTMENT MANAGEMENT LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.